|Articles|March 1, 2019
- Pharmaceutical Executive-03-01-2019
- Volume 39
- Issue 3
Pharmaceutical Executive, March 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Patient Advocacy: The Corporate Mandateabout 7 years ago
Patient Support Programs: Cost, Benefit, and Resourcingabout 7 years ago
Patients is a Virtueabout 7 years ago
What Does Patient Centricity Look Like?about 7 years ago
John Crowley: Living the Missionabout 7 years ago
Research Bonds Strengthenabout 7 years ago
Parallel Trade a Victim of Brexit Collateral Damageabout 7 years ago
Multiple Pharma Issues Top Congressional Agendaabout 7 years ago
Pharm Exec Joins MJH Portfolioabout 7 years ago
Cystic Fibrosis: The Importance of Patient AdvocacyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration’s Leadership Carousel Across Key Agencies
2
FDA Approves Foundayo Under National Priority Voucher Program
3
The New Antitrust Era: Why CVS-Style Healthcare Integration is Now the FTC’s Primary Target
4
More Than Just Pricing: MFN’s Impact on Pharma: Q&A with Lindsay Bealor Greenleaf
5